WO2010128232A3 - Méthode de diagnostic des infections à propionibacterium acnes - Google Patents

Méthode de diagnostic des infections à propionibacterium acnes Download PDF

Info

Publication number
WO2010128232A3
WO2010128232A3 PCT/FR2010/050765 FR2010050765W WO2010128232A3 WO 2010128232 A3 WO2010128232 A3 WO 2010128232A3 FR 2010050765 W FR2010050765 W FR 2010050765W WO 2010128232 A3 WO2010128232 A3 WO 2010128232A3
Authority
WO
WIPO (PCT)
Prior art keywords
seq
diagnosing
propionibacterium acnes
infections
acnes infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2010/050765
Other languages
English (en)
Other versions
WO2010128232A2 (fr
Inventor
Camille Cyncynatus
Julie ROGÉ
Hélène NUYTTENS
Damien Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
InGen BioSciences
Original Assignee
InGen BioSciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by InGen BioSciences filed Critical InGen BioSciences
Publication of WO2010128232A2 publication Critical patent/WO2010128232A2/fr
Publication of WO2010128232A3 publication Critical patent/WO2010128232A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une méthode de diagnostic in vitro d'une infection par une bactérie du genre Propionibacterium chez un individu, comprenant la détection d'anticorps dirigés contre au moins une protéine représentée par une séquence sélectionnée dans le groupe constitué de SEQ ID NO : 2, SEQ ID NO : 4, SEQ ID NO : 6, SEQ ID NO: 8, SEQ ID NO: 10, et SEQ ID NO: 12, dans un échantillon biologique de l'individu.
PCT/FR2010/050765 2009-05-04 2010-04-21 Méthode de diagnostic des infections à propionibacterium acnes Ceased WO2010128232A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0952946 2009-05-04
FR0952946A FR2945125B1 (fr) 2009-05-04 2009-05-04 Methode de diagnostic des infections a propionibacterium acnes

Publications (2)

Publication Number Publication Date
WO2010128232A2 WO2010128232A2 (fr) 2010-11-11
WO2010128232A3 true WO2010128232A3 (fr) 2011-01-06

Family

ID=41394941

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2010/050765 Ceased WO2010128232A2 (fr) 2009-05-04 2010-04-21 Méthode de diagnostic des infections à propionibacterium acnes

Country Status (2)

Country Link
FR (1) FR2945125B1 (fr)
WO (1) WO2010128232A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2594580B1 (fr) 2011-11-15 2016-05-18 Diaxonhit Procédé pour le diagnostic des infections bactériennes à propionibacterium
JP6916216B2 (ja) * 2016-06-13 2021-08-11 イー アンド エス ヘルスケア カンパニー リミテッド ファージディスプレイ技術を用いたにきび菌に特異的に結合するヒト抗体およびその用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081581A2 (fr) * 2000-04-21 2001-11-01 Corixa Corporation Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire
WO2008092201A1 (fr) * 2007-02-02 2008-08-07 Tissugen Pty Ltd Procédé de diagnostic de maladie prostatique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081581A2 (fr) * 2000-04-21 2001-11-01 Corixa Corporation Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire
WO2008092201A1 (fr) * 2007-02-02 2008-08-07 Tissugen Pty Ltd Procédé de diagnostic de maladie prostatique

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BROOK I ET AL: "Anaerobic osteomyelitis and arthritis in a military hospital: A 10-year experience", AMERICAN JOURNAL OF MEDICINE,, vol. 94, no. 1, 1 January 1993 (1993-01-01), pages 21 - 28, XP023222662, ISSN: 0002-9343, [retrieved on 19930101] *
DATABASE EMBL EBI; 13 September 2004 (2004-09-13), XP002559818, retrieved from EBI Database accession no. Q6AA73 *
M-F LUTZ ET AL: "Arthroplastic and osteosynthetic infections due to Propionibacterium acnes: a retrospective study of 52 cases, 1995-2002", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, SPRINGER, BERLIN, DE, vol. 24, no. 11, 1 November 2005 (2005-11-01), pages 739 - 744, XP019355299, ISSN: 1435-4373 *

Also Published As

Publication number Publication date
FR2945125A1 (fr) 2010-11-05
FR2945125B1 (fr) 2013-07-19
WO2010128232A2 (fr) 2010-11-11

Similar Documents

Publication Publication Date Title
WO2011135194A3 (fr) Procédé pour diagnostiquer un risque de diabète de type 1 et prévenir le déclenchement d'un diabète de type 1
EP2292648A3 (fr) Petits antigènes pyogènes streptococcus et leur utilisation
EP1982993A3 (fr) Détection des infections principales avec des pathogènes
GB0722105D0 (en) Antigens
WO2010135431A3 (fr) Compositions, dispositifs, et procédés relatifs à l'antigène membranaire spécifique de la prostate (psma)
WO2015196192A3 (fr) Procédés et compositions liées au virus de la dengue
WO2012103337A3 (fr) Dosages et procédé de séquençage de microbes directement à partir de complexes immuns
WO2012049225A3 (fr) Séquences de marqueur pour lupus érythémateux systémique et leurs utilisations
WO2017125892A3 (fr) Anticorps monoclonaux spécifiques de l'antigène piii d'adénovirus humain (adv), produits et sécrétés par des hybridomes cellulaires, utiles pour la détection et le diagnostic de l'infection causée par l'adv
WO2007030391A3 (fr) Procede de diagnostic d'infections
WO2012051372A3 (fr) Antigènes immunoréactifs de mycoplasma haemofelis et immunoessai diagnostique
FR2896588B1 (fr) Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3.
WO2010142906A3 (fr) Antigenes proteiques destines au serodiagnostic des infections a staphylococcus aureus notamment sur protheses osteo-articulaires
WO2012042062A3 (fr) Séquences de marqueurs pour la sclérose multiple et utilisation desdites séquences de marqueurs
WO2008120006A3 (fr) Dosage diagnostique
DE602005012530D1 (de) Immunogene glykopeptide zur diagnose von infektionen pathogener mikroorganismen
WO2012140148A3 (fr) Plakoglobine (jup) pour diagnostic de maladies cardiovasculaires
WO2009115508A3 (fr) Peptides luttant contre s. pneumoniae et compositions, méthodes et utilisations associées
EP2045328A4 (fr) Sequences peptidiques et nucleotidiques d'anisakis spp., anticorps qui reconnaissent ces sequences et leurs applications
JP2015510876A5 (fr)
BR112014022145A2 (pt) peptídeos de interferência e método para detecção de micro-organismos
ATE511646T1 (de) Diagnose mykobakterieller infektionen mittels bestimmung von ifn-gamma
WO2007101664A3 (fr) Test d'aspergillose amélioré dans des essais cliniques
WO2018051071A9 (fr) Détection et traitement d'une infection provoquée par microsporidie
WO2010046592A3 (fr) Utilisation de polypeptides isolés ayant des propriétés antigéniques vis-à-vis de mycoplasma pneumoniae, ainsi que des polynucléotides et anticorps correspondants

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10723716

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10723716

Country of ref document: EP

Kind code of ref document: A2